000 01014 a2200289 4500
005 20250514014756.0
264 0 _c20020408
008 200204s 0 0 eng d
022 _a1089-3261
024 7 _a10.1016/s1089-3261(05)70208-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCotler, S J
245 0 0 _aTreatment of hepatitis C virus and HIV co-infections.
_h[electronic resource]
260 _bClinics in liver disease
_cNov 2001
300 _a1045-61 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aHIV Infections
_xcomplications
650 0 4 _aHepatitis C
_xcomplications
650 0 4 _aHumans
650 0 4 _aInterferons
_xtherapeutic use
650 0 4 _aRibavirin
_xtherapeutic use
650 0 4 _aTime Factors
700 1 _aJensen, D M
773 0 _tClinics in liver disease
_gvol. 5
_gno. 4
_gp. 1045-61
856 4 0 _uhttps://doi.org/10.1016/s1089-3261(05)70208-7
_zAvailable from publisher's website
999 _c11602541
_d11602541